期刊文献+

益肾活血汤抗单侧输尿管梗阻大鼠肾间质纤维化作用及机制的研究 被引量:1

The Antagonizing Effect and Mechanism of Yishenhuoxue Decoction on Renal Interstitial Fibrosis of Unilateral Ureteral Obstruction Rats
下载PDF
导出
摘要 目的探讨益肾活血汤对大鼠肾间质纤维化的拮抗作用及机制。方法将60只大鼠随机分为假手术组、模型组、益肾活血汤治疗组、贝那普利治疗组。制备单侧输尿管梗阻(UUO)大鼠模型,在术后第21日处死大鼠留取梗阻侧肾组织观察肾间质病理变化,并用免疫组化法测定肾组织中纤溶酶原激活剂抑制物-1(PAI-1)、转化生长因子-β(TGF-β)及结缔组织生长因子(CTGF)的表达,处死前留取24 h尿测定尿蛋白,心腔穿刺取血测定血清尿素氮(BUN)、血清肌酐(Scr)。结果益肾活血汤组24 h尿蛋白、BUN、Scr水平、肾间质纤维化程度及PAI-1、TGF-β、CTGF的表达量均明显低于模型组(P<0.05),但与贝那普利组差异无统计学意义(P>0.05)。结论益肾活血汤对肾间质纤维化具有拮抗作用,其机制可能为通过减少PAI-1、TGF-β、CTGF等致纤维化因子在肾组织中的过度表达来抑制肾间质纤维化。 Objective:To investigate the antagonizing effect and mechanism of Yishenhuoxue decoction on renal interstitial fibrosis of unilateral ureteral obstruction (UUO) rats.Methods:Sixty SD rats were randomly assigned to shame operation group,operation model group,Yishenhuoxue decoction group and Benazepril group after unilateral ureteral obstruction.Rats were killed on the 21 day after operation.Renal tissues were examined by HE stain.Immunohistochemistry was performed for plasminogen activator inhibitor-1 (PAI-1),transforming growth factor-β (TGF-β) and connective tissue growth factor (CTGF) in renal interstitium.BUN,Scr and 24 hours urinary protein quantity were measured.Results:The fibrosis index values,the expression of PAI-1,TGF-β,CTGF protein and the level of BUN,Scr,24 hours urinary protein quantity in Yishenhuoxue decoction group were significantly lower than those in model group (P< 0.05).There were no significant differeces between Yeshenhuoxue decoction group and Benazepril group (P> 0.05).Conclusion:Yeshenhuoxue decoction possesses antagonizing effects on renal interstitial fibrosis by depressing the expression of PAI-1,TGF-β,CTGF protein.
出处 《中国中医急症》 2014年第12期2182-2183,2199,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 湖南省教育厅科研项目(12C0278) 湖南省教育厅科研项目(12C0269)
关键词 益肾活血汤 肾间质纤维化 PAI-1 TGF-β CTGF Yishenhuoxue decoction Renal interstitial fibrosis PAI-1 TGF-β CTGF
  • 相关文献

参考文献8

  • 1Nangaku M. Mechanisms of tubulointerstitial injury in the kindney:final common pathways to end-stage renal fail- ure [ J ~. Intern Med, 2004,43 ( 1 ) : 9-17.
  • 2Ishidoya S,Ogata,Fukuzaki A,et al. Plasminogen activator inhibitor-1 and tissue-type plasminogen activator are up- regulated during unilateral ureteral obstruction in adult rats [J]. J Vrol,2002,167(3) : 1503-1507.
  • 3Radford MG Jr, Donadio Jv Jr, Bergshralh E J, et al.Predieting renal outcome in IgA nephropathy [J ]. Am Soc Nephml, 1997, 8(2) : 199-207.
  • 4秦蓉.PAI-1及其在肾小球硬化中的作用及意义[J].临床与实验病理学杂志,1998,14(6):579-581. 被引量:8
  • 5Hamano K,lwano M,Akai Y,et al. Expression of g!omerular plasminogen activator inhibitor type 1 in glomerulonephri- tis [J]. Am J Kidney Dis ,2002,39(6) :695-705.
  • 6Gore-Hyer E,Shegogue D,Markiewiez M,et al. TGF-beta and CTGF have overlapping and distinct fibrogenie effects on human renal cells [J ]. Am J Physiol Renal Physiol, 2002,283 (4) :F707-716.
  • 7Ha H, Oh EY, Lee HB. The role of plasminogen activator in- hibitor 1 in renal and cardiovascular diseases [ J ]. Nat Rev Nephrol.2009,5 (4) : 203-211.
  • 8向彩春,熊清玓,曾礼华.益肾活血方对肾纤维化大鼠PCⅢ、Ⅳ-C及LN干预的实验研究[J].四川中医,2011,29(3):35-38. 被引量:6

二级参考文献26

  • 1于梅,李淑菊,王今朝,宋立群,迟继铭,张佩青.肾衰胶囊对慢性肾衰竭肾功能及纤维化指标影响的临床研究[J].中医药学报,2006,34(1):47-49. 被引量:9
  • 2胡兴荣,崔显念,徐先早.糖尿病肾病HA、LN、PCⅢ、Ⅳ-C检测及其临床意义[J].检验医学与临床,2007,4(3):168-169. 被引量:19
  • 3Nerlieh A, Sehleeher E. Immunohistoehemieal loealization of extraeeeular matrix components in human diabetic glomerular lesions [ J]. Am J Pathol, 1991, 139 (4): 889.
  • 4Kneio GS, Neilson EG, Haverty T, et al. Meehanisms oftubulointerstitial fibrosis [J]. Kidney Int, 1991, 39:550-556.
  • 5Koya D, Jirousek MR, Lin YW, et al. Characteriation ofprotein kidnase C beta isoform activation on the gene expression of transforming growth factor beta, extra cellular matrix components, and prostanoidsin the glomeruli of diabetic rats [ J]. J Clin Invest, 1997, 100 ( 1 ) : 115.
  • 6Mignatti P.Extracellular matrix remodeling by metalloproteinases and plasminogen activators.Kiddy Int,1995,47(suppl):S12-14.
  • 7Schnaper HW. Balance between matrix synthesis and degradation:a determinant of glomerulosclerosis. Pediatr Nephrol,1995,9(1):104-111.
  • 8Bosma PJ, Eva A, Van den Berg, Kooistra T, et al. Human plasminogen activator inhibitor-1 gene.J Biol Chem, 1998,263(19):9129-9141.
  • 9Bruzdzinski CJ, Johnson MR, Nordhy EC,et al.lsolation and characterization of the rat plasminogen activator inhibitor-1 gene.J Biol Chem,1990,265(4):2078-2085.
  • 10Simpson AJ,Booth NA,Moore NR,et al.Distribution of plasminogen activator inhibitpor (PAI-1)in tissue.Am J Pathol,1991,44:139-143.

共引文献12

同被引文献8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部